Benralizumab (Fasenra)

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

No FDA approval for hematology/oncology conditions, at this time.

General information

Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).

Diseases for which it is used

Patient Drug Information

Also known as

  • Brand names: Fasenra

References